Retrovir Capsule
Product Images NDC 49702-211

4 FDA label images from Viiv Healthcare Company · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Retrovir (NDC 49702-211). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Viiv Healthcare Company, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Zidovudine Structural Formula (Retrovir Spl Graphic 01)

Zidovudine Structural Formula (Retrovir Spl Graphic 01)
Chemical structure of zidovudine (RETROVIR), shown as a 2D molecular diagram with atoms and bonds illustrating the active ingredient in oral solution form by ViiV Healthcare Company.*
FDA Label Image

Retrovir Capsule 100 mg 100 Count Label (Retrovir Spl Graphic 02)

Retrovir Capsule 100 mg 100 Count Label (Retrovir Spl Graphic 02)
RETROVIR capsules containing 100 mg of zidovudine per capsule. The label shows a white capsule image with printed text. Packaged as 100 capsules. Manufactured by ViiV Healthcare, with storage instructions at 15° to 25°C and protection from moisture. The label includes the ViiV Healthcare logo and NDC 49702-211-20.*
FDA Label Image

Retrovir Oral Solution 240 mL Carton (Retrovir Spl Graphic 03)

Retrovir Oral Solution 240 mL Carton (Retrovir Spl Graphic 03)
RETROVIR (zidovudine) oral solution 10 mg/mL in a 240 mL container. The label instructs pharmacists to ensure caregivers have syringes with 0.1-mL graduation for accurate dosing in neonates. Manufactured by ViiV Healthcare Company, made in Canada, with copyright and trademark information included.*
FDA Label Image

Retrovir Iv 20 mL Vial 5 Count Carton (Retrovir Spl Graphic 04)

Retrovir Iv 20 mL Vial 5 Count Carton (Retrovir Spl Graphic 04)
RETROVIR (zidovudine) Injection 10 mg/mL solution label for 5 single-use vials of 20 mL each. The label includes instructions that the solution must be diluted prior to intravenous infusion and indicates the product is sterile and prescription only. NDC 49702-213-26, distributed by ViiV Healthcare Company.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.